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Abstract. In recent years there has been a global decrease in the prevalence of malaria due to scaling up of control measures, 
hence global control efforts now target elimination and eradication of the disease. However, a major problem associated 
with elimination is asymptomatic reservoir of infection especially in endemic areas. This study aims to determine the 
efficiency of histidine rich protein II (HRP-2) based rapid diagnostic tests (RDT) for monitoring transmission intensities in 
an endemic community in Nigeria during the pre-elimination stage. Plasmodium falciparum asymptomatic malaria 
infection in healthy individuals and symptomatic cases were detected using HRP-2. RDT negative tests were re-checked 
by microscopy and by primer specific PCR amplification of merozoite surface protein 2 (msp-2) for asexual parasites and 
Pfs25 gene for gametocytes in selected samples to detect low level parasitemia undetectable by microscopy. The mean age 
of the study population (n=280) was 6.12 years [95% CI 5.16 – 7.08, range 0.5 – 55], parasite prevalence was 44.6% and 
36.3% by microscopy and RDT respectively (p =0.056). The parasite prevalence of 61.5% in children aged >2 – 10 years 
was significantly higher than 3.7% rate in adults >18years (p < 0.0001, χ2 = 60.45). RDT detected additional 29.6% 
asymptomatic cases but a lower specificity of 68.8% in symptomatic carriers. In 15 selected RDT positive samples, only 6 
were positive by PCR and no gametocyte was detected. The results indicate that HRP-2 RDTs are a vital tool for 
understanding transmission dynamics and detecting immune-suppressed, recent and asymptomatic infections, thus crucial 
to tackle low level transmission and eliminating malaria in endemic areas. 
INTRODUCTION 
For decades, Plasmodium falciparum malaria caused great public health burdens globally, defying control efforts 
but in recent years, there have been success in reducing transmission, morbidities and mortality in different regions 
[1,2]. Hence global efforts now target eliminating the infection in different regions with an ultimate aim of eradicating 
the disease [3]. Achieving this goal of successful elimination in endemic areas require reliable epidemiologic data and 
close monitoring of transmission. In Nigeria, an estimated 110 million malaria cases and over 300,000 deaths are 
recorded per year [4]. A pooled analysis of epidemiological studies in Nigeria was used to estimate the past and current 
state of malaria transmission in Nigeria, showing the importance of community and National surveys, indeed 
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transmission rates are declining in Nigeria [5]. Rapid diagnostic tests (RDTs) and light microscopy are both 
recommended for malaria diagnosis in areas and countries that are eliminating malaria [3]. RDTs are very useful for 
epidemiological studies in endemic areas because they are simple, easy to use for field studies, requiring no skills and 
having different antigenic targets [6-9]. However, there are challenges of variable specificity, sensitivity, false 
positives, false negatives, availability, and quality of RDTs outcomes hence requiring continued monitoring. Studies 
have reported variable HRP-2 RDT tests based on age and infection rates, post-treatment persistence of parasite 
antigens, level of immunity and in different endemic settings [10, 11]. RDTs generally diagnose P. falciparum malaria 
with a sensitivity of >90% [8, 12-16], an advantage in endemic areas will be detection of asymptomatic parasitemia. 
Hence, HRP-2 RDTs could serve as a tool for mapping intensities of transmission in untreated population, because 
HRP-2 protein can be detected both in asexual parasites and from young gametocytes of P. falciparum. In P. 
falciparum infected red blood cells, merozoite surface protein 2 (msp 2) is a highly expressed; a study has reported 
the diversity of falciparum infections in this area, thus can reliably be used to confirm P. falciparum infections [17]. 
RDTs can solve problems of misdiagnosis at low parasitemia, and missed detection by microscopy which can be 
detected through parasite antigens [7, 9, 18]. After several years of implementing different control measures, 
transmission intensities would have declined but the intensities of transmission continue to vary in different 
communities and over time in Nigeria [4]. It is thus imperative to utilize fast, economical, consistent and accurate 
combined techniques for studying transmission dynamics in this endemic area during the pre-elimination phase. This 
study aims to improve on RDT methods for malaria diagnosis by evaluating the current rate of transmission in an 
endemic community using microscopy, RDT and polymerase chain reaction (PCR) for assessing transmission 
intensities in Ota, southwest Nigeria. 
MATERIALS AND METHODS 
The study was carried out in Ota, a metropolitan city in Ogun state, southwest Nigeria where malaria transmission 
occurs throughout the year but highest during the rainy season (April to October) when average rainfall is about 107.3 
mm. The annual temperature ranges from 22.8oC to 39oC. The cross-sectional study was carried out in individuals 
participating in voluntary community health survey in Ota during the dry season. The inclusion criteria include: 
individuals with no history of taking antimalarial treatment two weeks prior to sampling, and informed consent to 
participate in the study. Exclusion criterion was prior treatment for malaria within two weeks before the test. Ethical 
approval was sought from the local authority and the community leader to carry out the study. 
Laboratory test: Presence of malaria parasite was detected by histidine rich protein II (HRP-2) rapid diagnostic 
test (RDT) kits following the manufacturer’s instruction (Standard Diagnostic Inc. Hagal-Dong, Korea). Briefly, blood 
sample (10ul) was placed in the blood well of the cassette and few drops of the flushing buffer was also placed into 
the buffer well, the test was read within 15 minutes according to the manufacturer’s guide. Two lines at the control 
and test regions respectively indicates a positive result while a single line at the control region indicates a negative 
result. If no line appeared in the control region, the test was read as invalid. Thick smears were prepared for 
microscopy, dried, stained with Giemsa, and viewed under the microscope at 100x magnification by a trained 
personnel to determine presence of parasites. Negative slides were re-examined by an independent microscopist. 
Polymerase chain reaction amplification of block 3 region of msp-2 followed DNA extraction using Aidlab® tissue 
extraction kit, and methods previously described [17, 19] was used at a final volume of 25ul. Briefly, RNA extraction 
from blood spotted on filter paper was done using Promega ® kit in RDT false positive samples, cDNA was 
synthesized using TRUEscript H- RTase/RNase inhibitor and 2X reverse transcription mix, RNA was incubated at 
25oC for 10minutes, 42oC for 50 minutes and reaction terminated at 65oC for 15 minutes. Amplification of Pfs25 gene 
was done according to the method of Mlambo and colleagues [20] in a final volume of 25μl on Thermal cycler 
(BIORAD 2000). The PCR amplicons were resolved on a 2% agarose gel and visualized under UV transillumination 
for gel documentation. Data was analysed using SPSS for continuous data, while qualitative data was analysed using 
Microsoft Excel. 
RESULTS 
Overall, 280 individuals (100 symptomatic and 180 healthy participants) with mean age, 6.12 years (95% CI 5.16 
– 7.08, range 0.5 – 55) were evaluated for the presence of malaria parasites in the study area. Figure 1 shows the age 
distribution of parasite prevalence in the study group, 91.2% malaria cases were recorded in children aged < 10 years 
and prevalence was highest in children aged >2 – 10 years (p < 0.0001, χ2 = 60.45) while older children and adults 
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accounted for only <10% cases. Malaria parasite was demonstrable in 125 blood smears with a prevalence rate of 
44.6%. This was significantly higher than 36.3% prevalence rate by RDT (p = 0.056). In the positive cases, 38% were 
asymptomatic infection and 26.7% of this was detectable by RDT. In the blood films taken from symptomatic 
individuals, RDT sensitivity was relatively low, detecting only 53 of 77 (68.8%) positive cases with 2 invalid results.  
 
FIGURE 1. Age distribution and parasite positivity rate in the study population. Children aged >2 – 10 years had the highest 
population and parasite prevalence during the study. 
 
Microscopy negative and RDT positive (false positive results) were tested for true positivity using PCR. Fifteen 
successfully amplified samples showed 6 samples to be positive, a positivity rate of 40% for msp2 gene in the 
asymptomatic group, but there were no detectable gametocytes by RT-PCR in these samples. Figure 2 shows the gel 
image of PCR amplification for msp-2, of the 6 samples positive for msp-2, 3 distinct bands are seen while others were 
faintly seen. In these RDT false positive samples, parasitemia was not detected by microscopy. The parasite prevalence 
by RDT was re-calculated as corrected RDT parasite prevalence rate of 38.4%, this rate was similar to microscopy 
prevalence rate (p = 0.165, χ2 = 1.92). 
 
 
FIGURE 2. Gel image showing amplified msp2 gene (gene size 380bp) in some microscopy negative samples [L = 1kilobase 
DNA ladder, 1 – 15 are samples, Lanes 2, 6, 8, are distinctly positive samples while lanes 1, 3, 9 were slightly positive]. 
DISCUSSION 
Malaria transmission in highly endemic areas occur all year round but in recent times, there is declining 
transmission and associated deaths globally and in many endemic countries, due to adoption of artemisinin based 
combination therapies, distribution and use of long lasting insecticide treated nets, vector control and scaling up of 
other control measures [1, 3]. This trend applies also to Nigeria where geospatial data indicates that transmission rates 
continue to decline over many years of implementing malaria control, highlighting the importance of strategic control 
of malaria. The reported epidemiological survey in different communities across the country provides such evidence 
[5]. In this era of declining transmission, the success of malaria elimination will depend largely on accurate diagnosis 
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and epidemiological data which are both crucial for targeted interventions of disease control [3]. Challenges of 
correctly estimating transmission rates which mitigates the control strategies in endemic areas can be overcome. 
Microscopy remains the standard for malaria diagnosis which requires highly skilled personnel. It however can be 
subjective, laborious, and sometimes present with problems of identifying artifacts as parasites. When malaria expert 
is unavailable or for field studies, RDTs are recommended. Our study compared HRP-2 RDT efficiency, sensitivity 
and reliability with microscopy for determining the transmission intensity of malaria in a metropolitan community in 
southwest Nigeria, and the contribution of asymptomatic infection to the transmission intensity. The present study 
reports a transmission rate of about 40% in symptomatic and healthy individuals in which the latter contributes more 
than half (26%) of the total infection. Malaria prevalence in this study was significantly higher than rates reported in 
hospital population from some southwest region [14-15] but similar to rates reported in other southwest and Northern 
Nigeria [16, 21-23]. The reasons for this are not farfetched, our study evaluated both healthy and hospital population 
thus revealing the intensities of malaria transmission in a general population. It is obvious that transmission intensities 
are very dynamic, changing with factors modulating transmission; such as climate, vector efficiency and location due 
to intensified control efforts [24-25].  
Global reports on the status of malaria eradication indicate about 7 of the 43 endemic African countries with more 
than 25% population still at risk of malaria. Our reported rate is higher than that reported in countries in the African 
region and other regions outside the region working towards malaria elimination with very low rates e.g. < 10% in 
Papau New Guinea, Haiti etc, [2, 3]. Although, declining rates are reported in Nigeria over several years [5], our 
findings which is limited to a community in a sub-region of Nigeria showed a high transmission rate especially 
asymptomatic infection. Success of malaria eradication in endemic areas will benefit from a systematic review of 
prevalence rates using uniform diagnosis criteria such as RDT and microscopy used in the present study. It is also 
crucial to assess the effectiveness of these tools periodically to plan the needed strategies for different stages of 
elimination. True positivity of RDT was tested using PCR for msp-2 which was detectable in 6 samples, the other 
PCR-negative results may be due to recent infection detectable by persistent parasite antigens or presence of young 
gametocytes [6, 7, 18], although mature gametocytes were not detected in this study. A recent study reported that in 
this region, falciparum infections are multiclonal with high diversities within the msp-1, msp-2 and glurp genes. 
Multiplicity of infections has been linked to transmission intensities and is thought to also have important implications 
for epidemiology of drug-resistant parasites [17]. Although family specific alleles were not determined, by 
implication, our findings may be suggestive that transmission and resistant isolates are high in this region. 
Development of resistance in P. falciparum cause significant public health impact including increasing morbidity, 
mortality and reversal of successes of malaria control efforts [1-3]. Msp-2 detection in 40% false positive results by 
PCR further validates and corrects RDT outcomes. Detection of parasite antigen after clearance of infection by 
immunity which increases with malaria exposure, prior antimalarial use may explain possible reasons for RDT false 
positivity in the remaining samples. This sensitivity of  RDT was >95%, while PCR-corrected prevalence of 38.4% 
was similar to microscopy prevalence rate (44.6%), this supports reports of high sensitivity but variable specificity 
reported in other studies [11-12, 14-15, 26], this falls within recommended rates by the World Health Organization 
[13].  
Low level circulating asymptomatic infections which contributes significantly to malaria transmission is common 
in endemic areas [27-33]. Studies reports up to 30–50% cases of missed infections diagnosed by RDT and microscopy 
are detectable by PCR [28-29]. Our study confirms this as a major drawback for estimated malaria intensities in 
endemic areas due to limited resources for carrying out PCR, thus a poor reflection of the true transmission rates. 
Malaria control through artemisinin based chemotherapy has proved very effective in this area [34-35]; however 
understanding malaria dynamics, monitoring transmission in the pre-elimination stage in an endemic area is essential 
and will require combined control tools. Some antimalarials have potentials to reduce transmission e.g. sulphadoxine-
pyrimethamine, artemisinin derivatives and 8-aminoquinolines e.g. primaquine, by reducing gametocytes with 
significant declines in transmission [36-42], but are not recommended in this area, hence it continues to sustain parasite 
transmission in endemic areas as well as other low endemic regions [26, 27, 29-31, 43]. About 4% gametocyte carriage 
rates have been reported previously in Nigeria [34]; current gametocyte carriage rates in Nigeria in healthy individuals 
are unknown.  There are limitations of the present study: the true negativity of microscopy results were not determined, 
further studies would be carried out to validate this and improve the monitoring of transmission intensities, ultimately 
to reduce asymptomatic parasitic infection. Further studies are required to determine gametocyte prevalence and 
molecular markers of antimalarial resistance in the study area. Effective diagnosis and drug treatment will impact 
greatly on the risk of infection in the future and malaria elimination [4, 44]. In conclusion, malaria HRP-2 rapid 
diagnostic test kits have demonstrated high efficiency and may find usefulness in endemic areas to monitor low level 
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asymptomatic infection and for monitoring transmission intensities during the elimination stage in an endemic area 
such as in the present study area. 
ACKNOWLEDGMENTS 
We acknowledge the funding support of Covenant University Centre for Research Innovation and Development 
(CUCRID), Nigeria. We also thank all the individuals who participated in the study.  
REFERENCES 
1. R. W. Snow, P. Amratia, C. W. Kabaria, A. M. Noor, and K. Marsh, Adv. Parasitol. 78, 169-262 (2012). 
2. World Health Organization, (World malaria report, Geneva, 2014). 
3. World Health Organization, (W.H.O publication, Geneva, ISBN 978-92-4-151198-8, 2017). 
4. National Malaria Elimination Programme (NMEP), National Population Commission (NPopC), National Bureau 
of Statistics (NBS), and ICF International, Abuja, Nigeria, and Rockville, Maryland, USA: NMEP, NPopC, and 
ICF International (2016). 
5. National Malaria Control Programme (NMCP), suMAP, World Health Organization and the INFORM Project, 
A report prepared for the Federal Ministry of Health, Nigeria, the Roll Back Malaria Partnership and the 
Department for International Development (United Kingdom, 2013). 
6. J. P. Guthman, A. Ruiz, G. Priotto, J. Kiguli, L. Bonte, and D. Legros, Trans. R. Soc. Trop. Med. Hyg. 96, 254-
257 (2002). 
7. A. H. Moody, and P. L. Chiodini, J. Biomed. Sc. 59, 228-231 (2002). 
8. C. Wongsrichanalai, M. J. Barcus, S. Muth, A. Sutamihardja, and W. H. Wernsdorfer, Am. J. Trop. Med. Hyg. 
77(S6), 119–127 (2007). 
9. P. Jain, B. Chakma, S. Patra, and G. Goswami, BioMed. Res. Int. Article ID 852645, 20 pages, 
http://dx.doi.org/10.1155/2014/852645 (2014). 
10. J. R. Forney, A. J. Magill, C. Wongsrichanalai, J. Sirichaisinthop, C. T. Bautista, D. G. Heppner, R. S. Miller, 
C. F. Ockenhouse, A. Gubanov, R. Shafer, C. C. DeWitt, H. A. Quino-Ascurra, K. E. Kester, K. C. Kain, D. S. 
Walsh, W. R. Ballou, and R. A. Gasser Jr., J. Clin. Microbiol. 39, 2884–2890 (2001). 
11. A. Laurent, J. Schellenberg, K. Shirima, S. C. Ketende, P. L. Alonso, H. Mshinda, M. Tanner, and 
D. Schellenberg, Malar. J. 9, 294 (2010). 
12. K. Abba, J. J. Deeks, P. L. Olliaro, C. M. Naing, S. M. Jackson, Y. Takwoingi, S. Donegan, and P. Garner, 
Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD008122.DOI: 
10.1002/14651858.CD008122.pub2. 
13. World Health Organisation, (W.H.O publication, Geneva, ISBN 978 92 4 150256 6, 2011). 
14. O. Ajumobi, K. Sabitu, P. Nguku, J. Kwaga, G. Ntadom, S. Gitta, R. Elizeus, W. Oyibo, P. Nsubuga, M. Maire, 
and G. Poggensee, Am. J. Trop. Med. Hyg. 92, 828–833 (2015). 
15. O. K. Olaniyan, A. W. Oyibo, C. Okangba, T. O. Awesu, O. Odeniyi, V. N. Okeke, F. A. Adegoriola, V. N. 
Akpunonu, J. Elendu, T. Nuga, A. E. Orgah, T. Salihu, and S. O. Etatuvie, Cov. J Phy. Life Sc. 3, 29-44 (2015). 
16. I. Abdulkadir, A. H. Rufai, S. O. Ochapa, M. S. Malam, B. I. Garba, A. Y. Oloko, and I. I. George, Niger Med. 
J. 56, 278-82 (2015). 
17. G. I. Olasehinde, C. S. Yah, R. Singh, O. O. Ojuronbge, A. A. Ajayi, N. Valecha, A. O. Abolaji, and A. O. 
Adeyeba, Afr. Health Sc. 12, 355-361 (2012). 
18. R. Bodker, H. A. Msangeni, W. Kisinza, and S. W. Lindsay, Am. J. Trop Med. Hyg. 74, 716-723 (2006). 
19. A. Aubouy, F. Migot-Nabias, and P. Deloron, Malar. J. 2, 12 (2003). 
20. G. Mlambo Y. Vasquez, R. LeBlanc, D. Sullivan, and N. Kumar, Am. J. Trop. Med. Hyg. 78, 114–116 (2008). 
21. Z. Sheyin, and I. E. Bigwan, J. Med. Med. Sc. 4, 353-356 (2013). 
22. S. Dawaki, H. M. AlǦ Mekhlafi, I. Ithoi, J. Ibrahim, W. M. Atroosh, A. M. Abdulsalam, H. Sady, F. N. Elyana, 
A. U. Adamu, S. I. Yelwa, A. Ahmed, M. A. AlǦ Areeqi, L. R. Subramaniam, N. A. Nasr, and YǦ L Lau, Malar. 
J. 15, 351 (2016). 
23. R. I. Ilesanmi, O. A. Olalubi, O. T. Adetunde, A. O. Ilesanmi, H. Effedua, and A. O. Amoo, Malar. World J. 8, 
17 (2017). 
24. Federal Ministry of Health. National malaria and vector control programme, training manual for management of 
malaria in Nigeria. Kaduna, Nigeria, (2008). 
030001-5
25. O. O. Okwa, F. I. Akinmolayan, V. Carter, and H. Hurd, Ann. Afr. Med. 8, 1–9 (2009). 
26. D. R. Bell, D. W. Wilson, and L. B. Martin, Am. J. Trop. Med. Hyg. 73, 199–203 (2005). 
27. A. C. Hani, E. Lyons, and C. J. Drakeley, J. Infect. Dis. 12, 1509-1517 (2009). 
28. T. Bousema, l.Okell, I. Felger, and C. Drakeley, Nat. Rev. Microbiol. 12, 833-840 (2014). 
29. J. T. Lin, D. L. Saunders, and S. R. Meshnick, Trends Parasitol. 30, 183–190 (2014). 
30. S. Ganguly, P. Saha, S. K. Guha, A. Biswas, S. Das, P. K. Kundu, and A. K. Maji, J. Clin. Microb. 51, 1439–
1444 (2013). 
31. Z. Zhou, R. M. Mitchell, S. Kariuki, C. Odero, P. Otieno, K. Otieno, P. Onyona, V. Were, R. E. Wiegand, 
J. E. Gimnig, E. D. Walker, M. Desai, and Y. P. Shi, Malar. J. 15, 421 (2016). 
32. G. R. Atelu, N. O. Duah, and M. D. Wilson, Ghana Med. J. 50, 220-227 (2016). 
33. M. T. Zaw, M. Thant, T. M. Hlaing, N. Z. Aung, M. Thu, K. Phumchuea, K. Phusri, T. Saeseu, R. Yorsaeng, W. 
Nguitragool, I. Felger, J. Kaewkungwal, L. Cui, and J. Sattabongkot, Malar. J. 16, 138 (2017). 
34. G. O. Gbotosho, A. Sowunmi, C. T. Happi, and T. M. Okuboyejo, Mem. do Inst. Oswaldo Cruz 106, 685 – 690 
(2011). 
35. S. Oguche, H. U. Okafor, I. Watila, M. Meremikwu, P. Agomo, W. Ogala, C. Agomo, G. Ntadom, O. Banjo, T. 
Okuboyejo,G. Ogunrinde, F. Odey, O. Aina, T. Sofola, and A. Sowunmi, Am. J Trop. Med. Hyg. 91, 925 – 935 
(2014). 
36. A. Dicko, J. M. Brown, H. Diawara, I. Baber, A. Mahamar, H. M. Soumare, K. Sanogo, F. Koita, S. Keita, S. F. 
Traore, I. Chen, E. Poirot, J. Hwang, C. McCulloch, K. Lanke, H. Pett, M. Niemi, F. Nosten, T. Bousema, and 
R. Gosling, Lancet Infect. Dis. 16, 674–684 (2016). 
37. J. Okebe, T. Bousema, M. Affara, G. L. D. Tanna, E. Dabira, A. Gaye, F. Sanya-Isijola, H. Badji, S. Correa, D. 
Nwakanma, J. V. Geertruyden, C. Drakeley, and U. D'Alessandro, EBioMed. 13, 348-355 (2016). 
38. G. Newby, J. Hwang, K. Koita, I. Chen, B. Greenwood, L. von Seidlein, G. D. Shanks, L. Slutsker, S. P. Kachur, 
J. Wegbreit, M. M. Ippolito, E. Poirot, and R. Gosling, Am. J. Trop. Med. Hyg. 93, 125–134 (2015). 
39. I. Chen, S. E. Clarke, R. Gosling, B. Hamainza, G. Killeen, A Magill, W. O’Meara, R. N. Price, and E. M. Riley, 
PLoS Med. 13, e1001942 (2016). 
40. B. P. Goncalves, A. B. Tiono, A. Ouedraogo, W. M. Guelbeogo, J. Bradley, I. Nebie, D. Siaka, K. Lanke, A. C. 
Eziefula, A. Diarra, H. Pett, E. C. Bougouma, S. B. Sirima, C. Drakeley, and T. Bousema, BMC Med. 14, 40 
(2016). 
41. W. R. J Taylor, EBiomed. 14, 5-6 (2016). 
42. E. Rovira-Vallbona, J. J. Contreras-Mancilla, R. Ramirez, M. Guzmán-Guzmán, G. Carrasco-Escobar, A. 
Llanos-Cuentas, J. M. Vintez, D. Gamboa, and A. Rosanas-Urgell, PLoS Negl. Trop. Dis. 11, e0005674 (2017).  
43. A. C. Guerra, W. P. Gikandi, J. A. Tatem, A. M. Noor, L. D. Smith, I. S. Hay, and W. R. Snow, PLoS Med. 5, 
38 (2008). 
44. A. B. Tiono, A. Ouédraogo, B. Ogutu, A. Diarra, S. Coulibaly, A. Gansané, S. B. Sirima, G. O’Neil, A. 
Mukhopadhyay, and K. Hamed, Malar. J. 12, 79 (2013). 
030001-6
